CurrentCardio
Get Weekly

Topic · page 4 of 21

Prevention & lipids

Lipids, Lp(a), lifestyle (activity, diet, alcohol, smoking), risk scores, primary prevention in general or older populations, frailty and CV risk

Briefs 121–160 of 838 placed here, newest publication first

Briefs in Prevention & lipids

Newest publication first

  1. JAMA Cardiol

    Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease

    Cohort study

  2. JAMA Cardiol

    Projected US Cardiovascular Disease Burden From Heat Exposure for Future Greenhouse Gas Scenarios

    Cross-sectional study

  3. JACC Adv

    Public Awareness of Sex Differences in Cardiovascular Disease: A Nationwide Population Study

    Cross-sectional study

  4. Eur J Prev Cardiol

    Technology-assisted physical activity among hospitalized medical patients: a cluster randomized trial

    Randomised controlled trial

  5. Eur Heart J Cardiovasc Pharmacother

    Statin adherence among patients with hypertension in Swedish primary health care: a QregPV cohort study using explainable machine learning

    Cohort study

  6. Eur J Prev Cardiol

    Cardiovascular health score, social network size, and all-cause mortality in a Korean prospective cohort

    Cohort study

  7. Eur J Prev Cardiol

    Indications, protocols, and interpretation of cardiovascular imaging for the evaluation and management of athletes: a clinical consensus statement of the European Association of Preventive Cardiology (EAPC) and the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC), Part 2: Cardiovascular magnetic resonance, cardiac CT, and nuclear imaging

    Guideline or statement

  8. Eur J Prev Cardiol

    Indications, protocols, and interpretation of cardiovascular imaging for the evaluation and management of athletes: a clinical consensus statement of the European Association of Preventive Cardiology (EAPC) and the European Association of Cardiovascular Imaging (EACVI) of the ESC: Part 1—Exercise imaging

    Guideline or statement

  9. Eur Heart J Cardiovasc Imaging

    Indications, protocols, and interpretation of cardiovascular imaging for the evaluation and management of athletes: a clinical consensus statement of the European Association of Preventive Cardiology (EAPC) and the European Association of Cardiovascular Imaging (EACVI) of the ESC: Part 1—Exercise imaging

    Guideline or statement

  10. JACC Adv

    Cardiovascular Health Profiles in Pregnant, Postpartum, and Nonpregnant Reproductive-Aged Women Using Life’s Essential 8 Scores

    Cross-sectional study

  11. JACC Adv

    Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study

    Secondary analysis

  12. Eur J Prev Cardiol

    Loneliness, unhealthy lifestyle, and incident cardiometabolic disease among middle-aged and older adults across 33 countries: a multicohort study

    Cohort study

  13. JACC Adv

    Discordance Between Perceived Risk and Cardiovascular Health in Women of Reproductive Age

    Cross-sectional study

  14. Eur J Prev Cardiol

    Exercise blood pressure relative to fitness in male elite athletes: stage-specific response patterns and athlete-specific reference limits

    Cross-sectional study

  15. JACC Adv

    Triglyceride-Glucose-Waist-to-Height Ratio Index and Left Ventricular Diastolic Function in Military Athletes

    Cross-sectional study

  16. JACC Adv

    A Novel Approach to Manage Hypercholesterolemia: Veterans Affairs Lipid Optimization Reimagined Quality Improvement Program

    Research article

  17. JACC Adv

    Artificial Intelligence–Enabled Serial Electrocardiograms for Prediction of All-Cause Mortality in Secondary Care Settings

    Cohort study

  18. Eur J Prev Cardiol

    Interaction between air pollution and genetic predisposition to blood pressure and low-density lipoprotein cholesterol on cardiovascular events

    Research article

  19. Eur Heart J Cardiovasc Pharmacother

    Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation

    Research article

  20. Eur Heart J

    Genetic screening of children for familial hypercholesterolaemia: the VRONI study

    Cohort study

  21. Eur J Prev Cardiol

    Persistent social connection over time is associated with attenuated biological ageing assessed by AI-enabled electrocardiography

    Cohort study

  22. Eur Heart J

    Cholesterol-lowering therapy from childhood/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study

    Cohort study

  23. J Am Coll Cardiol

    Combined LDL-C, Lp(a), and hsCRP Assessment Predicts ASCVD in the Multiethnic HELIUS Cohort

    Cohort study

  24. Eur J Prev Cardiol

    Cardiorespiratory exercise intensity prescription in cardiovascular rehabilitation: do updated guideline recommendations reflect real individual effort responses?

    Cohort study

  25. Eur J Prev Cardiol

    Cardiovascular disease risk among young adults with disabilities: a nationwide cohort study

    Cohort study

  26. Eur Heart J

    Statins and survival free of incident frailty among older US veterans

    Cohort study

  27. J Am Coll Cardiol

    Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

    Guideline or statement

  28. Circulation

    Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

    Guideline or statement

  29. Eur J Prev Cardiol

    Joint association of genetic risk and accelerometer-based step count with cardiovascular disease: a UK Biobank cohort study

    Cohort study

  30. Eur J Prev Cardiol

    Objectively measured individual-level daytime vs. night-time light exposure and cardiovascular disease mortality in US adults

    Cohort study

  31. Eur J Prev Cardiol

    The emerging role of coronary computed tomography for the prevention of cardiovascular disease in asymptomatic individuals

    Research article

  32. Eur Heart J

    Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model

    Diagnostic or prognostic study

  33. Eur J Prev Cardiol

    Lipoprotein(a) and residual cardiovascular risk in statin-treated patients

    Cohort study

  34. Eur J Prev Cardiol

    Target trial emulation of alcohol intake interventions in young adults and risk of cardiovascular disease over 30 years: data from the CARDIA study

    Cohort study

  35. Eur J Prev Cardiol

    Accelerated vascular ageing: an early prognostic signal for risk stratification and prevention

    Research article

  36. Eur Heart J

    Safety of low lipoprotein(a) levels: the FOURIER trial

    Secondary analysis

  37. Circulation

    Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable Cardiometabolic Health: MRI-Assessed 5- and 10-Year Follow-Up After 2 Clinical Trials

    Secondary analysis

  38. Circulation

    Role of Physical Activity in Obesity Treatment and Cardiometabolic Health: A Scientific Statement From the American Heart Association

    Guideline or statement

  39. Eur Heart J Qual Care Clin Outcomes

    Comparison of different long-term cardiovascular disease risk prediction horizons to guide preventive drug treatment in apparently healthy individuals

    Research article

  40. JAMA Cardiol

    Response to PCSK9 Inhibition Based on LDL Receptor Function in Familial Hypercholesterolemia: A Nonrandomized Clinical Trial

    Research article

All 838 Briefs in ExploreShowing Briefs 121–160 of 838, newest first